Exploring the Future of the Pharmaceutical Industry and the Healthcare System â The Benefits of Electronic Health Records Becoming a Reality (original) (raw)

Abstract

While a commonly accepted view on the future healthcare system is yet to emerge, a number of generally acknowledged trends already exist that are shaping that future system. The costs and timelines for developing new and innovative medicines are continuing to reach unprecedented heights. 1 There is an acute need for It is important to note that reusing EHR data for clinical research purposes is anything but straightforward. Data collected for and

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (51)

  1. Adams CP, Brantner VV, Spending on new drug development, Health Econ, 2010;19(2):130-41.
  2. Sundgren M, New needs for interoperability in clinical research, presented at the 2010 World Health IT Conference, Barcelona, Spain, 2010.
  3. goodman C, Comparative Effectiveness Research and Personalized Medicine: From Contradiction to Synergy, The Lewin group Centre for Comparative Effectiveness Research, 2009.
  4. Byrne D, European Commissioner for Health and Consumer Protection, Enabling good Health for all -A Reflection Process for a new EU Health Strategy, European Commission, 15 July 2004. Available at: http://ec.europa.eu/health/ph\_overview/Documents/byr ne_reflection_en.pdf
  5. Australian government -Department of Health and Ageing, Key Priority Area 3: Increasing the focus on prevention, Building a 21st Century -Primary Health Care System -Australia's First National Primary Health Care Strategy, AgDHA, 20 May 2010. Available at: www.health.gov.au/internet/yourhealth/publishing.nsf/C ontent/550436A8DA6839ECCA25771B00220E23/$File/65 52%20NPHC%201205.pdf
  6. Thiers FA, Sinskey AJ, Berndt ER, Trends in the globalization of clinical trials, Nat Rev Drug Discov, 2008;7:13-14.
  7. PricewaterhouseCoopers, Transforming Healthcare Through Secondary use of Health Data, PWC, 2009.
  8. Kahn Mg, Integrating Electronic Health Records and Clinical Trials -An Examination of Pragmatic Issues. University of Colorado, The Children's Hospital Denver, 2006. Ensuring the Inclusion of Clinical Research in the National Health Information Network.
  9. American Medical Informatics Association, NHIN Slipstream Project, AMIA Meeting on Pharmacovigilance, Accenture, 13 June 2007. Abailable at: www.amia.org/files/nhinslipstream.pdf
  10. Bain LC, CDISC/IHE/HIMSS: Demonstrating Healthcare to Clinical Research Interoperability, EHR Considerations for Clinical Data Management, 43rd DIA Annual Meeting, Atlanta, 2007.
  11. El Fadly A, Daniel C, Bousquet C, et. al., Electronic healthcare record and clinical research in cardiovascular radiology. HL7 CDA and CDISC ODM interoperability, AMIA Annu Symp Proc, 2007:216-20.
  12. Fridsma DB, Evans J, Hasttak S, et al., The BRIDg project: A technical report, J Am Med Inform Assoc, 2008;15(2): 130-37.
  13. SemanticHEALTH report, Semantic Interoperability for Better Health and Safer Healthcare, European Commission Information Society and Media, 2009. Available at: http://ec.europa.eu/information\_society/ activities/health/docs/publications/2009/2009semantic- health-report.pdf
  14. Cuggia M, EHR use for recruiting patients in oncology trials, 22nd Annual Euromeeting, Monaco, 8-10 March 2010.
  15. Patel C, Khan S, gomadam K, TrialX: Using Semantic Technologies to Match Patients to Clinical Trials based on their Personal Health Records, Applied Informatics Inc, 2009. Available at: www.cs.vu.nl/\~pmika/swc/ documents/TrialX-healthx-iswc09-challenge.pdf
  16. Thadani SR, Weng C, Bigger JT, et al., Electronic screening improves efficiency in clinical trial recruitment, J Am Med Inform Assoc, 2009;16:869-73.
  17. Ibara M, A Collaborative Study To Improve Drug Safety, The *ASTER Pilot Project: Improving the Reporting of Adverse Events, ASTER, 2009. Available at: http://www.asterstudy.com
  18. Ibara M, Bain LC, Zafar A, et al., ASTER one year later: a new business model for postmarketing reporting, 45th Annual Meeting, Drug Information Association, San Diego, 2009.
  19. Innovative Medicines Innitiative. 2009 Call Topics, IMI, 2009:57-63. Available at: http://imi.europa.eu/docs/imi- ju-2009-call-topics-14092009_en.pdf
  20. Partnership to Fight Chronic Disease, 2009 Almanac of Chronic Disease, Partnership to Fight Chronic Disease, 2009. Available at: www.fightchronicdisease.org/pdfs/ 2009_PFCDAlmanac.pdf
  21. PhRMA, Just What the Doctor Ordered: Taking Medicines as Prescribed Can Improve Health and Lower Costs, PhRMA, March 2009. Available at: www.phrma.org/files/ attachments/Adherence.pdf
  22. Osterberg L, Blaschke T, Adherence to medication, N Engl J Med, 2005;353:487-97.
  23. WellDoc, Our Products, WellDoc Inc, 2010. Available at: www.welldocinc.com/Products-and-Services/Our- Products.aspx
  24. Merck Sharp & Dohme, Wellness Connected. Vree for Diabetes, MSD, 2010. Available at: http://www.vree- health.com
  25. SymCare, Our Programs. inTouch.dibetes, SymCare Personalized Health Solutions Inc, 2008. Available at: www.symcare.com/ourprograms.html
  26. Bayer, gLUCOFACTS ® Deluxe Software, Bayer HealthCare LLC, 2010. Available at: /www.simplewins.com/site/Adults/Monitor/Pages/Bayer- Products/gLUCOFACTS-Deluxe-Software
  27. Quinn CC, Sysko Clough S, Minor JM, et. al., WellDoc™ mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction, Diabetes Technology & Therapeutics, 2008;10:160-68.
  28. Quinn CC, gruber-Baldini AL, Shardell M, et al., Mobile diabetes intervention study: Testing a personalized treatment/behavioral communication intervention for blood glucose control, Contemp Clin Trials, 2009;30(4): 334-46.
  29. US National Institutes of Health, Evaluation of gLUCOFACTS ® Deluxe Diabetes Management System, clinicaltrials.gov, 1 May 2009. Available at: http://clinicaltrials.gov/ct2/show/NCT00892151
  30. Proteus Biomedical, Intelligent Medicine in Heart Failure, Proteus Biomedical, 2007. Available at: www.proteusbiomed.com/proteus\_products.html
  31. Corventis, NUVANT™ Mobile Cardiac Telemetry (MCT) System, Corventis Inc, 2009.
  32. Mandl KD, Kohane IS, Tectonic shifts in the health information economy, N Engl J Med, 2008;358:1732-7.
  33. Tang PC, Ash JH, Bates DW, et al., Personal health records: definitions, benefits, and strategies for overcoming barriers to adoption, J Am Med Inform Assoc, 2006;13:121-6.
  34. Deloitte, Electronic Health Record (EHR) Data: Modernizing the Pharmaceutical Research Process, Deloitte Consulting LLP, 2009.
  35. Sarkar IN, Biomedical informatics and translational medicine, J Transl Med, 2010;8:22.
  36. Perkslis ED, Van Dam J, Szalma S, How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development, Clin Pharmacol Ther, 2010:87:614-16.
  37. Lean MEJ, Translational Research: from evidence-based medicine to sustainable solutions for public health problems, BMJ, 2008;337:a863.
  38. Hiss Rg, Fundamental issues in translational research; translational research -two phases of a continuum. In: From Clinical Trials to Community: the Science of Translating Diabetes and Obesity Research, National Institute of Health, 2004:11-19.
  39. Kane JM, Review of treatments that can ameliorate nonadherence in patients with schizophrenia, J Clin Psychiatry, 2006;67:9-14.
  40. Weber V, Bloom F, Pierdon S, Employing the electronic health record to improve diabetes care: a multifaceted intervention in an integrated delivery system, J Gen Intern Med, 2008;23:379-82.
  41. Enrado P, The business case for using EHRs as a prevention tool, EHRWatch, 3 February 2010. Available at: http://ehrwatch.com/blog/business-case-using-ehrs- prevention-tool
  42. Friedberg MW, Coltin KL, Safran Dg, et al., Associations between structural capabilities of primary care, Ann Intern Med, 2009;151:456-63.
  43. Kaushal R, The value of EHRs, The Healthcare Imperative: Lowering Costs, Improving Outcomes. Roundtable on Evidence-Based Medicine, Institute of Medicine, July 2009. Available at: ww.iom.edu/~/media/Files/ Activity%20Files/Quality/VSRT/Cost%202/4- The%20Value%20of%20EHRs.ashx
  44. World Health Organization, The WHO Agenda, WHO, 2010. Available at: www.who.int/about/agenda/en/ index.html
  45. Vital Wave Consulting, mHealth for Development: The Opportunity of Mobile Technology for Healthcare in the Developing World, UN Foundation-Vodafone Foundation Partnership, 2009.
  46. AppLab, Mobile Technology for Community Health (MoTeCH). AppLab -Transforming Lives through Innovation in Informaiton Access, grameen Foundation, 2009. Available at: www.grameenfoundation.applab.org/ section/ghana-health-worker-project
  47. Fogarty International Center, Hopkins program taps into Uganda's technology resources, global Health Matters, 2009;8:6. Available at: http://www.fic.nih.gov/news/ publications/global_health_matters/ghmnov-dec2009.pdf 50. eMOCHA, eMOCHA electronic Mobile Open-source Comprehensive Health Application, 2010. Available at: http://emocha.org
  48. Robertson J, DeHart D, An agile and accessible adaptation of Bayesian inference to medical diagnostics for rural health extension workers, Proceedings of AAAI Artificial Intelligence for Development, 2010:134-35.
  49. World Health Partners, Technologies, World Health Partners, 2009. Available at: www.worldhealth partners.org/about_technologies.htm
  50. Christensen CM, The Innovator's Prescription, Mcgraw-Hill, 2009.
  51. Bloomrosen M, Detmer DE, Informatics, evidence-based care, and research; implications for national policy: a report of an American Medical Informatics Association health policy conference, J Am Med Inform Assoc, 2010;17: 115-23.